Zolar, a Germany-based solar-powered energy system installer, has raised €15m in an expansion of its series B round from a consortium including multiple corporate venturing units. The B round is now €25m following reinvestment from Inven Capital, corporate venture capital fund of Czech-based energy group CEZ Group supported by the European Investment Bank, Statkraft Ventures, a venture firm… Continue reading Zolar lights up with series B extension
Month: September 2020
Oncocross smiles with new round
Oncocross, a South Korea-based drug developer, has raised SKr16.5bn ($14m) in its series B round co-led by Smilegate Investment, the corporate venturing unit (formerly known as MVP Venture Capital) of local games company Smilegate. Other investors in the round included co-lead GN Tech Venture Capital, KDB Capital, Hana Financial Investment, Wooshin Venture Investment, Hanvit Investment,… Continue reading Oncocross smiles with new round
SoftBank joins Access All founder initiative
SoftBank will join UK-based venture capital firms Downing Ventures, Playfair Capital and SpeedInvest, as well as corporations Microsoft for Startups, Amazon, Accenture and O2 in supporting a virtual event geared toward founders from underrepresented groups. Held on 30 September after the GCV Digital Forum on the 29th, Access All is a joint initiative by Floww, Force Over Mass and Telefonica’s corporate… Continue reading SoftBank joins Access All founder initiative
Seeq adds Cisco to series B round
Seeq, a US-based analytics software provider for manufacturing and industrial internet of things, has closed its series B expansion round from a consortium including multiple corporate venturing units. Cisco Investments was a new investor in Seeq’s about-$30m expansion. This is in addition to previous series B funding, led by Altira Group and Saudi Aramco Energy… Continue reading Seeq adds Cisco to series B round
11 truths: lessons from 30 years of innovation
Comment from Michael Redding, former managing director, Accenture Ventures
The impact of covid-19 – an investor’s view
Comment from Boda Gallon, Health & social care consultant
World emerges with innovation in mind
September 2020 issue editorial by James Mawson, editor in chief, Global Corporate Venturing
Prenetics tests series C round with Alibaba
The testing services provider hiked its overall funding to more than $68m in a round backed by Alibaba Hong Kong Entrepreneurs Fund.
Baijiayun basks in $26.3m series B
Cash Capital was among the investors for Baijiayun, a Mooc platform whose shareholders also include Xiaodu Huyu, Huatu Education and BaishanCloud.
Chime rings $485m funding bell
Chime has increased its valuation nearly tenfold in 18 months and is worth $14.5bn following a $485m series F round that included existing shareholder Access Industries.
Roche fires up $448m Inflazome acquisition
Novartis-backed Inflazome, which advances University of Queensland and Trinity College Dublin research to develop treatments for inflammation, has been bought by Roche for $448m.
Compass Pathways navigates IPO
Compass Pathways has raised more than $127m in an upsized initial public offering that provided an exit to Otsuka Pharmaceuticals.
Kindred relates to LPs for $104m fund
Legal & General is among the limited partners for Kindred Capital’s second fund, which also attracted University of Chicago and will invest in early-stage European startups.
MPL scores $90m funding round
Telkom Indonesia and Go-Jek have thrown their weight behind Mobile Premier League’s latest funding round that will allow the esports platform to expand outside of India.